References
- Vosmik J, Jedlicka K, Mulder J L, Cort J H. Action of the a-triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology 1977; 72: 605–9
- Bende M, Flisberg K. Vasopressin for bleeding from the head and neck. Acta Otolaryngol (Stockh) 1979; 88: 459–61
- Pliska V, Chard T, Rudinger J, Forsling M L. In vivo activation of synthetic hormonogens of lysine vasopressin: N-glycyl-glycyl-glycyl-(8-lysine)-vasopressin in the cat. Acta Endocrinol 1976; 81: 474–81
- Shaldon S, Sherlock S. The use of vasopressin (“Pitressin”) in the control of bleeding from oesophageal varices. Lancet 1960; 2: 222–5
- Forsling M L, Aziz L A, Miller M, Davies R, Donovan B. Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 1980; 85: 237–44; 5
- Slotnick I L, Teigland J D. Cardiac accidents following vasopressin injection (Pitressin). JAMA 1951; 146: 1126–9
- Bende M, Flisberg K, Larsson I, Ohlin P, Olsson P. A method for determination of blood flow with 133Xe in human nasal mucosa. Acta Otolaryngol (Stockh) 1983; 96: 277–85
- Broms P, Jonson B, Lamm C J. Rhinomanometry. A system for numerical description of the nasal airway resistance. Acta Otolaryngol (Stockh) 1982; 94: 157–68
- Wyllie J W, Kern E B, O'Brien P C, Hyatt R E. Alteration of pulmonary function associated with arterial nasal obstruction. Surg Forum Mayo Clinic Rochester 1976; 27: 535–7
- Small M, Maran A GD. Epistaxis and arterial ligation. 3 Laryngol Otol 1984; 98: 281–4
- Cook T A, Komorn R M. Statistical analysis of the alterations of blood gases produced by nasal packing. Laryngoscope 1973; 83: 1802–09
- Slocum C W, Maisel R H, Cantrell R W. Arterial blood gas determination in patients with anterior packing. Laryngoscope 1976; 86: 869–73
- Cassisi N J, Biller H F, Ogura J H. Changes in arterial oxygen tension and pulmonary mechanics with the use of posterior packing in epistaxis: a preliminary report. Laryngoscope 1971; 81: 1261–6
- Lucente F E. Thanatology: A study of 100 deaths. Tr Am Acad Ophth Otol 1972; 76: 334–9
- Hara H J. Severe epistaxis. Arch Otolaryngol 1962; 75: 258–69
- Juselius H. Epistaxis a clinical study of 1724 patients. J Laryngol Otol 1974; 88: 317–27
- Kyncl J, Rezabek K, Kasafiiek E, Pliska V, Rudinger J. “Hormonogen” analogues of lysine vasopressin: rat pressor and antidiuretic activities. Eur J Pharmacol 1974; 28: 294–301
- Cort J H, Jeanjean M F, Thomson A E, Nickerson M. Effect of “hormonogen” forms of neurohy-pophysial peptides in hemorrhagic shock in dogs. Am J Physiol 1968; 214: 455–62
- Cort J H, Albrecht I, Novakova J, Mulder J L, Jost K. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity. Eur J Clin Invest 1975; 5: 165–75
- Bengtsson L P. Effect of a vasopressin analogue on myometrial activity in nonpregnant women. Physiology and Genetics of Reproduction, part B, E M Coutinho, F Fuchs. Plenum, New York 1975; 189–202
- Aronsen K F, Wetterlin S, Emås S, Vojtisek V, Mulder J L, Cort J H. Die Wirkung von Triglycyl-Lysin-Vasopressin auf Kontrollpersonen und Patienten mit Blutungen des oberen Gastrointesti-naltraktes. Klin Wochenschr 1975; 53: 747–53
- Paulsson B, Bende M, Ohlin P. Nasal mucosal blood flow at rest and during exercise. Acta Otolaryngol (Stockh) 1985; 99: 140–3
- Olsson P, Bende M. The influence of environmental temperature on human nasal mucosa. Ann Otol Rhinol Laryngol 1985; 94: 153–5
- Mellander S, Johansson B. Control of resistance, exchange, and capacitance functions in the peripheral circulation. Pharmacol Rev 1968; 20: 117–96
- Altura B M. Selective microvascular constrictor actions of some neurohypophyseal peptides. Eur J Pharm 1973; 24: 49–60